Research and Innovation Showcase 2025
Innovation, translation, and impact—building the future through research at Georgetown.
Wednesday, April 1st, 2025
1:30 PM to 6:30 PM ET
The Office of Technology Commercialization, in collaboration with Georgetown Entrepreneurship Initiative, is excited to announce the first Research and Innovation Showcase event. This half-day celebration will highlight discoveries, celebrate innovation, feature new ventures, and connect academia with industry and investors. The event includes research presentations, an industry panel discussion, and a venture fair presenting new, exciting entrepreneurial companies and teams from the Georgetown community.
Event Highlights (Please check back for updated agenda):
Research Presentations (1.30 PM-3.00 PM EST)
Dr. Louis Weiner delivering a Lecture
Explore the latest breakthroughs across key research areas in Life Sciences, MedTech, Physical Sciences, AI, and Software through through a short presentation from leading Georgetown researchers.
Industry Panel Discussion (3.00 PM- 4.00 PM)
OTC Panel Discussion 2015
Hear from industry leaders on how cutting-edge university research transitions into real-world solutions. We representative from the following companies:
Astrazeneca
Zachary Cooper, PhD
Senior Director, External R&D and Innovation, Oncology R&D, AstraZeneca
Dr. Zachary Cooper is a Senior Director of External R&D at AstraZeneca. As part of AstraZeneca for 9 years, Zachary has brought robust expertise in tumor immunology, the tumor microenvironment, and biomarker analysis in clinical samples/trials.
Dr. Cooper has initiated and managed external collaborations and alliances at AstraZeneca, influencing the portfolio’s strategy for various therapeutic areas including immuno-oncology, cell therapy and antibody drug-conjugates (ADCs). He previously led translational strategy for a variety of first time in human trials for immuno-oncology including the adenosine pathway (CD73 and CD39) and ADCs targeting B7H4.
Prior to AstraZeneca, he served as an Assistant Professor at MD Anderson Cancer Center in Surgical Oncology and Genomic Medicine, where he focused on understanding response and resistance to targeted therapies and immunotherapy for melanoma. Dr. Cooper obtained his PhD in Molecular Medicine from the University of Maryland, as well as Postdoctoral Fellowships at Brown University and Harvard Medical School/Massachusetts General Hospital. Dr. Cooper has authored over 80 manuscripts including those in Science, Nature, Cell, Nature Genetics, Lancet Oncology, Cancer Discovery, Cancer Cell, and others.
Georgetown Venture Fair (4.00 PM-5.00 PM)
2024 Innovation Award reception
A fast-paced venture fair featuring nine pitches from faculty, students, and alumni-led startups working on disruptive technologies. The event will attract investors, venture capitalists, angel investors, and corporate innovation teams eager to engage with emerging ventures.
Presenting Ventures:
- Faculty Startups: 2-3 selected startups
- Student Ventures: 2-3 selected startups
- Alumni Ventures: 2-3 selected startups
This event is a must-attend for researchers, entrepreneurs, investors, and industry partners eager to explore collaborations, funding opportunities, and commercialization pathways for innovative Georgetown technologies.
Networking reception (5.00 PM-6.30 PM)
2024 Innovation Awards Networking Highlights
Registration Information:
Please RSVP by March 24th, 2025, to secure your place at this prestigious celebration of innovation. Don’t miss this opportunity to connect with the Georgetown and regional innovation and entrepreneurship community.